Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia DA, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Edoxaban for the treatment of cancer-associated venous thromboembolism. New England Journal of Medicine. 2018 Feb 15; 378(7):615- 624. [PMID: 29231094].

Lanting V, van Bergen en Henegouwen K, Bosch F, Grosso M, Segers A, Raskob G, Kamphuisen T, Büller H, Verhamme P, Weitz J,? Di Nisio M, Carrier M, van Es N, Wang TF. Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post-hoc analysis of the Hokusai VTE Cancer study. Journal of Thrombosis and Hemostasis. 2025 Mar 4:S1538-7836(25)00120-5. [PMID: 40049418].

Wang TF, Kou R, Carrier M, Delluc A. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis. J Thromb Haemost. 2024 Mar;22(3):749-764. [PMID: 38065528].

Wang TF, Clarke A, Awan AA, Tanuseputro P, Carrier M, Sood MM. Hemorrhage risk in direct oral anticoagulant users receiving tamoxifen versus aromatase inhibitors for breast cancer. JAMA Network Open. 2022 Jun 1;5(6):e2219128. [PMID: 35763294].

Wang TF, Khorana AA, Agnelli G, Bloomfield D, Bonaca MP, Büller HR, Connors JM, Goto S, Jing ZC, Kakkar AK, Khder Y, Raskob GE, Soff GA, Verhamme P, Weitz JI, Carrier M. Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. Oncologist. 2023 Jul 5;28(7):555-564. [PMID: 37171998].